MASK-BP3 Activators
Activators of MASK-BP3 include a range of molecules that amplify the protein's activity through various intracellular pathways and molecular interactions. Certain activators work by stimulating the production of adenylate cyclase, thus causing an increase in cyclic AMP levels, which subsequently activates protein kinase A (PKA). PKA, a critical kinase, targets numerous substrates for phosphorylation, which is presumed to involve MASK-BP3, leading to its enhanced functional state. There are also compounds that prevent the breakdown of cAMP, thereby boosting PKA activity and potentially promoting the phosphorylation and activation of MASK-BP3. Others, mimicking cAMP, can directly stimulate PKA, implying an increase in MASK-BP3 activity. Some molecules act as receptor agonists, triggering a rise in cAMP production, supporting the involvement of PKA in the regulation of MASK-BP3.
Furthermore, certain chemicals activate protein kinase C (PKC), which in turn phosphorylates a variety of targets, possibly affecting MASK-BP3 and its activity level. Changes in intracellular calcium concentrations are also pivotal for MASK-BP3 modulation, as compounds that enhance calcium levels could activate calcium-dependent kinases that target MASK-BP3. The significance of cGMP in the regulation of MASK-BP3 is underscored by agents that elevate cGMP concentrations, thereby stimulating protein kinase G (PKG), which might then phosphorylate and activate MASK-BP3. Additionally, the activation of stress-responsive pathways, which involves kinases that respond to cellular stress, may also intersect with the regulatory mechanisms of MASK-BP3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases which increases intracellular cAMP by preventing its degradation, thereby potentiating PKA activation and subsequent phosphorylation of MASK-BP3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of Protein Kinase C (PKC) which can phosphorylate downstream proteins, potentially including MASK-BP3, resulting in its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A membrane-permeable cAMP analog that directly activates PKA, leading to enhanced phosphorylation of downstream proteins such as MASK-BP3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that raises intracellular calcium levels, possibly activating calmodulin-dependent kinases which can then activate MASK-BP3 by phosphorylation. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
L-type calcium channel agonist that increases intracellular calcium, potentially stimulating calcium-dependent kinases that might phosphorylate and activate MASK-BP3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic receptor agonist that increases cAMP production, leading to the activation of PKA which could then phosphorylate MASK-BP3. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Selective inhibitor of phosphodiesterase 5 (PDE5), increasing cGMP levels which can activate PKG, potentially leading to the phosphorylation and activation of MASK-BP3. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs) such as JNK, which can phosphorylate and activate various substrates, potentially including MASK-BP3. | ||||||
PKC-412 | 120685-11-2 | sc-200691 sc-200691A | 1 mg 5 mg | $52.00 $114.00 | 10 | |
Protein kinase inhibitor that has shown to selectively activate certain kinases at lower concentrations, potentially leading to the activation of MASK-BP3 through off-target effects. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) which may lead to compensatory activation of other kinases that could phosphorylate and activate MASK-BP3. | ||||||